Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Donald L Hertzog. (2004) Recent advances in the cannabinoids. Expert Opinion on Therapeutic Patents 14:10, pages 1435-1452.
Read now
Read now
Pilar Goya & Nadine Jagerovic. (2000) Recent advances in cannabinoid receptor agonists and antagonists. Expert Opinion on Therapeutic Patents 10:10, pages 1529-1538.
Read now
Read now
Roger G Pertwee. (2000) Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development. Expert Opinion on Investigational Drugs 9:7, pages 1553-1571.
Read now
Read now
Articles from other publishers (32)
J. M. Keppel Hesselink. (2015) The terms ‘autacoid’, ‘hormone’ and ‘chalone’ and how they have shifted with time. Autonomic and Autacoid Pharmacology 35:4, pages 51-58.
Crossref
Crossref
José Elguero, Artur M. S. Silva & Augusto C. Tomé. 2011. Modern Heterocyclic Chemistry. Modern Heterocyclic Chemistry
635
725
.
Lumír Ondřej Hanuš. (2008) Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids. Medicinal Research Reviews 29:2, pages 213-271.
Crossref
Crossref
Andrew S.C. Rice. 2007. Wall y Melzack. Tratado del Dolor. Wall y Melzack. Tratado del Dolor
533
551
.
Julia Adam, Phillip M. Cowley, Takao Kiyoi, Angus J. Morrison & Christopher J.W. Mort. 2006. Progress in Medicinal Chemistry Volume 44. Progress in Medicinal Chemistry Volume 44
207
329
.
Andrew S.C. Rice. 2006. Wall and Melzack's Textbook of Pain. Wall and Melzack's Textbook of Pain
521
539
.
Lumír O. Hanuš & Raphael Mechoulam. 2005. Cannabinoids as Therapeutics. Cannabinoids as Therapeutics
23
46
.
Frank Mauler, Ervin Horváth, Jean Vry, Rainer Jäger, Thomas Schwarz, Steffen Sandmann, Corinna Weinz, Roland Heinig & Michael Böttcher. (2006) BAY 38-7271: A Novel Highly Selective and Highly Potent Cannabinoid Receptor Agonist for the Treatment of Traumatic Brain Injury. CNS Drug Reviews 9:4, pages 343-358.
Crossref
Crossref
Frank Mauler, Volker Hinz, Karl-Heinz Augstein, Marion Faßbender & Ervin Horváth. (2003) Neuroprotective and brain edema-reducing efficacy of the novel cannabinoid receptor agonist BAY 38-7271. Brain Research 989:1, pages 99-111.
Crossref
Crossref
Peter G. Willis, Reeti Katoch‐Rouse & Andrew G. Horti. (2003)
Regioselective F‐18 radiolabeling of AM694, a CB
1
cannabinoid receptor ligand
. Journal of Labelled Compounds and Radiopharmaceuticals 46:9, pages 799-804.
Crossref
Crossref
Lidia Ruiz‐Llorente, María G. Sánchez, María J. Carmena, Juan C. Prieto, Manuel Sánchez‐Chapado, Adriana Izquierdo & Inés Díaz‐Laviada. (2002)
Expression of functionally active cannabinoid receptor CB
1
in the human prostate gland
. The Prostate 54:2, pages 95-102.
Crossref
Crossref
William B Mathews, Ursula Scheffel, Paige A Rauseo, Hayden T Ravert, Richard A Frank, George J Ellames, John M Herbert, Francis Barth, Murielle Rinaldi-Carmona & Robert F Dannals. (2002) Carbon-11 labeled radioligands for imaging brain cannabinoid receptors. Nuclear Medicine and Biology 29:6, pages 671-677.
Crossref
Crossref
Frank Mauler, Joachim Mittendorf, Ervin Horváth & Jean de Vry. (2002)
Characterization of the Diarylether Sulfonylester (−)-(
R
)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a Potent Cannabinoid Receptor Agonist with Neuroprotective Properties
. Journal of Pharmacology and Experimental Therapeutics 302:1, pages 359-368.
Crossref
Crossref
. 2002. The Biology of Marijuana. The Biology of Marijuana
574
592
.
Roger G. Pertwee. 2002. Trends in Drug Research III. Trends in Drug Research III
249
258
.
M. -H. Thiébot & F. Chaperon. (2001) Effets comportementaux des cannabinoïdes Données animales. Douleur et Analgésie 14:4, pages 193-206.
Crossref
Crossref
Didier M. Lambert, Séverine Vandevoorde, Gérald Diependaele, Sophie J. Govaerts & Annie R. Robert. (2002) Anticonvulsant Activity of N-Palmitoylethanolamide, a Putative Endocannabinoid, in Mice. Epilepsia 42:3, pages 321-327.
Crossref
Crossref
William B Mathews, Ursula Scheffel, Paige Finley, Hayden T Ravert, Richard A Frank, Murielle Rinaldi-Carmona, Francis Barth & Robert F Dannals. (2000) Biodistribution of [18f] SR144385 and [18f] SR147963: selective radioligands for positron emission tomographic studies of brain cannabinoid receptors. Nuclear Medicine and Biology 27:8, pages 757-762.
Crossref
Crossref
Raphael Mechoulam & Lumı́r Hanuš. (2000) A historical overview of chemical research on cannabinoids. Chemistry and Physics of Lipids 108:1-2, pages 1-13.
Crossref
Crossref
Pierre Beaulieu, Tiziana Bisogno, Shahid Punwar, W.Paul Farquhar-Smith, Gerolmina Ambrosino, Vincenzo Di Marzo & Andrew S.C Rice. (2000) Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat. European Journal of Pharmacology 396:2-3, pages 85-92.
Crossref
Crossref
Paul Sharpe & Graham Smith. (2000) Cannabis: Time for Scientific Evaluation of This Ancient Remedy?. Anesthesia & Analgesia 90:2, pages 237-240.
Crossref
Crossref
Roger G. Pertwee. (2006) Neuropharmacology and therapeutic potential of cannabinoids. Addiction Biology 5:1, pages 37-46.
Crossref
Crossref
L. Hanuš, A. Breuer, S. Tchilibon, S. Shiloah, D. Goldenberg, M. Horowitz, R. G. Pertwee, R. A. Ross, R. Mechoulam & E. Fride. (1999)
HU-308: A specific agonist for CB
2
, a peripheral cannabinoid receptor
. Proceedings of the National Academy of Sciences 96:25, pages 14228-14233.
Crossref
Crossref
Didier M Lambert, Federica G DiPaolo, Pierre Sonveaux, Martial Kanyonyo, Sophie J Govaerts, Emmanuel Hermans, Jean-Luc Bueb, Nathalie M Delzenne & Eric J Tschirhart. (1999) Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB2 cannabinoid, as potential ligands for the cannabinoid receptors. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1440:2-3, pages 266-274.
Crossref
Crossref
Martial Kanyonyo, Sophie J. Govaerts, Emmanuel Hermans, Jacques H. Poupaert & Didier M. Lambert. (1999) 3-Alkyl-(5,5′-diphenyl)imidazolidinediones as new cannabinoid receptor ligands. Bioorganic & Medicinal Chemistry Letters 9:15, pages 2233-2236.
Crossref
Crossref
David Shire, Bernard Calandra, Monsif Bouaboula, Francis Barth, Murielle Rinaldi-Carmona, Pierre Casellas & Pascual Ferrara. (1999) Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528. Life Sciences 65:6-7, pages 627-635.
Crossref
Crossref
Roger G Pertwee. (1999) Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors. Life Sciences 65:6-7, pages 597-605.
Crossref
Crossref
Anthony S. Basile, Lumír Hanuš & Wallace B. Mendelson. (1999) Characterization of the hypnotic properties of oleamide. NeuroReport 10:5, pages 947-951.
Crossref
Crossref
E. M. Nakamura-Palacios, J. M. Moerschbaecher & L. A. Barker. (2006) The Pharmacology of SR 141716A: A Review. CNS Drug Reviews 5:1, pages 43-58.
Crossref
Crossref
Robert B Raffa, Dennis J StoneJr.Jr. & Sean J Hipp. (1999) Differential cholera-toxin sensitivity of supraspinal antinociception induced by the cannabinoid agonists Δ9-THC, WIN 55,212-2 and anandamide in mice. Neuroscience Letters 263:1, pages 29-32.
Crossref
Crossref
Jia-Ning Xiang & John C. Lee. 1999.
199
208
.
Elizabeth A. Kowaluk & Stephen P. Arneric. 1998.
11
20
.